MCL1 and neoplasm: Interestingly, we found increased Mcl-1/Bim interactions in fulvestrant-treated MCF7 xenografts (Fig. 3d,e), and in clinical ERα+ tumor specimens treated with Faslodex/Arimidex (Fig. 6a).